Soft Biomimetic Approach for the Development of Calcinosis-Resistant Glutaraldehyde-Fixed Biomaterials for Cardiovascular Surgery
-
Published:2023-08-10
Issue:4
Volume:8
Page:357
-
ISSN:2313-7673
-
Container-title:Biomimetics
-
language:en
-
Short-container-title:Biomimetics
Author:
Zvyagina Alyona I.1, Minaychev Vladislav V.1, Kobyakova Margarita I.1, Lomovskaya Yana V.1ORCID, Senotov Anatoliy S.1ORCID, Pyatina Kira V.12, Akatov Vladimir S.12ORCID, Fadeev Roman S.12, Fadeeva Irina S.12ORCID
Affiliation:
1. Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, 142290 Pushchino, Russia 2. Pushchino State Institute of Natural Science, 142290 Pushchino, Russia
Abstract
Pathological aseptic calcification is the most common form of structural valvular degeneration (SVD), leading to premature failure of heart valve bioprostheses (BHVs). The processing methods used to obtain GA-fixed pericardium-based biomaterials determine the hemodynamic characteristics and durability of BHVs. This article presents a comparative study of the effects of several processing methods on the degree of damage to the ECM of GA-fixed pericardium-based biomaterials as well as on their biostability, biocompatibility, and resistance to calcification. Based on the assumption that preservation of the native ECM structure will enable the creation of calcinosis-resistant materials, this study provides a soft biomimetic approach for the manufacture of GA-fixed biomaterials using gentle decellularization and washing methods. It has been shown that the use of soft methods for preimplantation processing of materials, ensuring maximum preservation of the intactness of the pericardial ECM, radically increases the resistance of biomaterials to calcification. These obtained data are of interest for the development of new calcinosis-resistant biomaterials for the manufacture of BHVs.
Funder
ITEB RAS State Assignment Russian Foundation for Basic Research
Subject
Molecular Medicine,Biomedical Engineering,Biochemistry,Biomaterials,Bioengineering,Biotechnology
Reference63 articles.
1. 2021 ESC/EACTS Guidelines for the management of valvular heart disease;Vahanian;Eur. Heart J.,2021 2. Santangelo, G., Bursi, F., Faggiano, A., Moscardelli, S., Simeoli, P.S., Guazzi, M., Lorusso, R., Carugo, S., and Faggiano, P. (2023). The Global Burden of Valvular Heart Disease. From Clinical Epidemiology to Management. J. Clin. Med., 12. 3. Aluru, J.S., Barsouk, A., Saginala, K., Rawla, P., and Barsouk, A. (2022). Valvular Heart Disease Epidemiology. Med. Sci., 10. 4. Mechanisms and Drug Therapies of Bioprosthetic Heart Valve Calcification;Wen;Front. Pharmacol.,2022 5. Development and trend in the field of valvular heart disease in China: An analysis based on the National Natural Science Foundation of China;Wen;Ann. Transl. Med.,2020
|
|